 The obese mice with diabetes that were given oral alanolic acid weighed significantly less and showed better blood sugar regulation than before treatment compared to control obese mice not receiving the alanolic acid. The glucose lowering effect was comparable with that of the injectable diabetic medication liraglutide. That is one of those GLP-1 injectable shots.